Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhendong Chen"'
Publikováno v:
Cancer Medicine
Objective To investigate the prospective memory (PM) impairment following whole brain radiotherapy (WBRT) in cancer patients with brain metastases. Method Eighty‐one patients with metastatic brain cancer, agreeing to undergo WBRT, were enrolled and
Autor:
Zhonglian Huang, Longsheng Wang, Huaidong Cheng, Chen Gan, Zhendong Chen, Qianqian Jia, Wen Li, Han Xuan
Publikováno v:
Oncotarget
// Han Xuan 1, * , Chen Gan 1, * , Wen Li 1 , Zhonglian Huang 1 , Longsheng Wang 1 , Qianqian Jia 1 , Zhendong Chen 1 and Huaidong Cheng 1, * 1 Department of Oncology, Cancer and Cognition Laboratory, The Second Affiliated Hospital of Anhui Medical U
Publikováno v:
Cancer Research. 81:CT157-CT157
Background: Chiauranib (CS2164) selectively inhibits multiple kinase targets, including Aurora B, vascular endothelial growth factor receptors, platelet-derived growth factor receptor, c-Kit and colony stimulating factor 1 receptor. Phase 1 studies s
Publikováno v:
Tumor Biology. 35:6011-6020
We performed a meta-analysis of cohort studies to determine whether promoter methylation of the death-associated protein kinase (DAPK) gene contributes to the pathogenesis of nonsmall cell lung cancer (NSCLC). A range of electronic databases were sea
Autor:
Zhen Yang, Mingjun Zhang, Biao Dong, Huaidong Cheng, Zhendong Chen, Chanjuan Chen, Kai Wang, Zhonglian Huang
Publikováno v:
Psycho-Oncology. 22:2391-2395
Objective This study aimed to investigate the event-based prospective memory (EBPM) and time-based prospective memory (TBPM) in chemotherapy-induced cognitive impairment in patients with breast cancer. Methods Forty patients with breast cancer who un
Autor:
Shiying Yu, Yiping Zhang, Binghe Xu, K. Gu, Junlan Yang, Fengchun Zhang, Zefei Jiang, Chuan Wang, Zhimin Shao, Shuping Song, Jifeng Feng, Jiayu Wang, Zhendong Chen
Publikováno v:
Cancer Chemotherapy and Pharmacology. 67:223-230
Fulvestrant, an oestrogen receptor (ER) antagonist with no known agonist effects, has shown activity in postmenopausal patients with ER-positive advanced breast cancer recurring or progressing following prior endocrine therapy. This double-blind, dou
Publikováno v:
Tumor Biology. 36:7303-7303
We performed a meta-analysis of cohort studies to determine whether promoter methylation of the death-associated protein kinase (DAPK) gene contributes to the pathogenesis of nonsmall cell lung cancer (NSCLC). A range of electronic databases were sea